NLS Pharmaceutics Ltd.

NAS: NLSP

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
NLS Pharmaceutics Ltd.

Market closed

NLSP
/zigman2/quotes/222659842/composite

$

0.84

Change

-0.0075 -0.88%

Volume

Volume 32,265

Sep 20, 2023, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/222659842/composite

Previous close

$ 0.85

$ 0.84

Change

-0.0075 -0.88%

Day low

Day high

$0.82

$0.86

Open
Open: 0.82

52 week low

52 week high

$0.42

$1.88

Open

Market cap

$27.48M

Average volume

98,935

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.84

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nlsp

MarketWatch News on NLSP

  1. NLS Pharmaceuticals downgraded to hold from buy at Maxim Group

    7:40 a.m. Sept. 14, 2023

    - Tomi Kilgore

  3. NLS Pharmaceuticals downgraded to hold from buy at Maxim Group

    12:08 p.m. Nov. 8, 2022

    - Tomi Kilgore

  4. NLS Pharmaceutics started at buy with $13.50 stock price target at Alliance Global Partners

    7:05 a.m. July 5, 2022

    - Tomi Kilgore

  5. NLS Pharmaceutics started at buy with $8 stock price target at Maxim Group

    8:50 a.m. March 3, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/nlsp

Other News on NLSP

  2. New Strong Sell Stocks for July 30th

    9:08 a.m. July 30, 2021

    - Zacks.com

/news/pressrelease/company/us/nlsp

Press Releases on NLSP

  13. NLS Pharmaceutics CEO Issues Letter to Shareholders

    9:32 a.m. Dec. 22, 2022

    - ACCESSWIRE

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.